Cargando…
Pharmacokinetics of Myo-Inositol in a Wistar Rat Animal Model
Myo-inositol is the most popular inositol in living organisms, where it is present as a sugar alcohol, in a free form, and can also be described as a lipid. The aim of this study was to check the concentration change of a myo-inositol solution from the time of oral administration and over a 48 h per...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9570207/ https://www.ncbi.nlm.nih.gov/pubmed/36232547 http://dx.doi.org/10.3390/ijms231911246 |
_version_ | 1784810049172930560 |
---|---|
author | Antonowski, Tomasz Osowski, Adam Szczesny, Damian Szablińska-Piernik, Joanna Juśkiewicz, Jerzy Lahuta, Lesław Rynkiewicz, Andrzej Wojtkiewicz, Joanna |
author_facet | Antonowski, Tomasz Osowski, Adam Szczesny, Damian Szablińska-Piernik, Joanna Juśkiewicz, Jerzy Lahuta, Lesław Rynkiewicz, Andrzej Wojtkiewicz, Joanna |
author_sort | Antonowski, Tomasz |
collection | PubMed |
description | Myo-inositol is the most popular inositol in living organisms, where it is present as a sugar alcohol, in a free form, and can also be described as a lipid. The aim of this study was to check the concentration change of a myo-inositol solution from the time of oral administration and over a 48 h period in Wistar-type rats. All rats received 2 g/kg of inositol as a solution in distilled water by oral gavage. Estimated parameters were based on the serum concentration of myo-inositol observed in nine individual rats with regard to time. Observations were described as a one-compartment pharmacokinetic model with first-order absorption and zero-order endogenous input of checked inositol. The highest myo-inositol concentration was observed in the first hour after oral administration in the serum of all tested rats. Then, the concentration began decreasing immediately after the maximal peak. The inositol concentration continued to decrease, but after 24 h its level was still higher than before the administration. The plasma profile of the myo-inositol concentration showed a rapid decline over time, possibly due to the metabolism of this compound. |
format | Online Article Text |
id | pubmed-9570207 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-95702072022-10-17 Pharmacokinetics of Myo-Inositol in a Wistar Rat Animal Model Antonowski, Tomasz Osowski, Adam Szczesny, Damian Szablińska-Piernik, Joanna Juśkiewicz, Jerzy Lahuta, Lesław Rynkiewicz, Andrzej Wojtkiewicz, Joanna Int J Mol Sci Article Myo-inositol is the most popular inositol in living organisms, where it is present as a sugar alcohol, in a free form, and can also be described as a lipid. The aim of this study was to check the concentration change of a myo-inositol solution from the time of oral administration and over a 48 h period in Wistar-type rats. All rats received 2 g/kg of inositol as a solution in distilled water by oral gavage. Estimated parameters were based on the serum concentration of myo-inositol observed in nine individual rats with regard to time. Observations were described as a one-compartment pharmacokinetic model with first-order absorption and zero-order endogenous input of checked inositol. The highest myo-inositol concentration was observed in the first hour after oral administration in the serum of all tested rats. Then, the concentration began decreasing immediately after the maximal peak. The inositol concentration continued to decrease, but after 24 h its level was still higher than before the administration. The plasma profile of the myo-inositol concentration showed a rapid decline over time, possibly due to the metabolism of this compound. MDPI 2022-09-24 /pmc/articles/PMC9570207/ /pubmed/36232547 http://dx.doi.org/10.3390/ijms231911246 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Antonowski, Tomasz Osowski, Adam Szczesny, Damian Szablińska-Piernik, Joanna Juśkiewicz, Jerzy Lahuta, Lesław Rynkiewicz, Andrzej Wojtkiewicz, Joanna Pharmacokinetics of Myo-Inositol in a Wistar Rat Animal Model |
title | Pharmacokinetics of Myo-Inositol in a Wistar Rat Animal Model |
title_full | Pharmacokinetics of Myo-Inositol in a Wistar Rat Animal Model |
title_fullStr | Pharmacokinetics of Myo-Inositol in a Wistar Rat Animal Model |
title_full_unstemmed | Pharmacokinetics of Myo-Inositol in a Wistar Rat Animal Model |
title_short | Pharmacokinetics of Myo-Inositol in a Wistar Rat Animal Model |
title_sort | pharmacokinetics of myo-inositol in a wistar rat animal model |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9570207/ https://www.ncbi.nlm.nih.gov/pubmed/36232547 http://dx.doi.org/10.3390/ijms231911246 |
work_keys_str_mv | AT antonowskitomasz pharmacokineticsofmyoinositolinawistarratanimalmodel AT osowskiadam pharmacokineticsofmyoinositolinawistarratanimalmodel AT szczesnydamian pharmacokineticsofmyoinositolinawistarratanimalmodel AT szablinskapiernikjoanna pharmacokineticsofmyoinositolinawistarratanimalmodel AT juskiewiczjerzy pharmacokineticsofmyoinositolinawistarratanimalmodel AT lahutalesław pharmacokineticsofmyoinositolinawistarratanimalmodel AT rynkiewiczandrzej pharmacokineticsofmyoinositolinawistarratanimalmodel AT wojtkiewiczjoanna pharmacokineticsofmyoinositolinawistarratanimalmodel |